Clinical Trials for Byondis

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Byondis

Clinical Trials (3)

NCT06932952
A Dose Escalation and Expansion Trial With BYON4228 Alone and in Combination in Patients With Advanced or Metastatic Solid Tumors
PHASE1Recruiting
85 participants
Started: May 7, 2025 · Completed: Sep 30, 2027
1 condition1 sponsor6 locations
NCT06359002
Safety, Pharmacokinetics, and Preliminary Efficacy of BYON4413 in Acute Myeloid Leukemia and Myelodysplastic Neoplasms.
PHASE1Recruiting
100 participants
Started: Jun 25, 2024 · Completed: Mar 31, 2027
2 conditions1 sponsor9 locations
NCT05737628
First-in-human Dose Escalation and Expansion Study With the SIRPα-directed Monoclonal Antibody BYON4228
PHASE1Recruiting
100 participants
Started: Mar 4, 2024 · Completed: Dec 1, 2025
1 condition1 sponsor12 locations